Marcos Valadares's guest appearances

Marcos Valadares

Finding Genius Podcast

SobreVasco

Na Base da Bola

J Scott

Bill Barhydt

Whitney Johnson

Alex Mashinsky

Ross Ulbricht

Lyn Ulbricht

Jameson Lopp

Marco Peereboom

Megan Ramos

Danny Flood

Abel James

Nir Eyal

Perry Marshall

Scott Young

Ben Goertzel

OwlTail

Em entrevista concedida ao canal do Leo e ao Na Base da Bola, o técnico Marcos Valadares contou sua história e sua visão de trabalho sobre o trabalho com o futebol de base. 

Em entrevista concedida ao canal do Leo e ao Na Base da Bola, o técnico Marcos Valadares contou sua história e sua visão de trabalho sobre o trabalho com o futebol de base.

Trabalho da base na visão do Marcos Valadares

No episódio de hoje a gente comenta a saída de Marcos Valadares do comando do sub20 do Vasco e debate o quanto isso pode impactar no rendimento da base. Confere aí. Para saber mais: www.youtube.com/sobrevasco

No episódio de hoje a gente comenta a saída de Marcos Valadares do comando do sub20 do Vasco e debate o quanto isso pode impactar no rendimento da base. Confere aí. Para saber mais: <a href="http://www.youtube.com/sobrevasco" rel="nofollow" target="_blank">www.youtube.com/sobrevasco</a>

MARCOS VALADARES FORA! (Isso pode afetar o Vasco?) | A notícia do dia #11

Pluricell Biotech was founded 4 years ago to derive and commercialize stem cells for research applications. Recently, they have made the switch into creating therapeutic applications from stem cell research, with a specific focus on the heart.Cells that still retain their neucleus are collected from healthy donors and “re-wound” to become pleuripotent stem cells, which can then be differentiated into heart cells. Currently, Pluricell is working on being able to replace scar tissue located in the heart, as well as other small areas of the heart where cells have died, and their ultimate goal is to be able to both regrow large sections of the heart, or to re-grow an entire organ, depending on the need of the patient. They have seen promising test results on small rodents–though because the hearts of these animals are different than those of humans, they are looking for approval to begin human trials. They believe that they could have that approval within the next 4-5 years, and in about 10 years would be able to take their research to market. For more information, visit www.pluricellbiotech.com.

Pluricell Biotech was founded 4 years ago to derive and commercialize stem cells for research applications. Recently, they have made the switch into creating therapeutic applications from stem cell research, with a specific focus on the heart.Cells that still retain their neucleus are collected from healthy donors and “re-wound” to become pleuripotent stem cells, which can then be differentiated into heart cells. Currently, Pluricell is working on being able to replace scar tissue located in the heart, as well as other small areas of the heart where cells have died, and their ultimate goal is to be able to both regrow large sections of the heart, or to re-grow an entire organ, depending on the need of the patient. They have seen promising test results on small rodents–though because the hearts of these animals are different than those of humans, they are looking for approval to begin human trials. They believe that they could have that approval within the next 4-5 years, and in about 10 years would be able to take their research to market. For more information, visit <a href="http://www.pluricellbiotech.com" rel="nofollow" target="_blank">www.pluricellbiotech.com</a>.

Pluricell Biotech — Marcos Valadares, Founder and CEO — Creating Therapeutic Applications from Stem Cell Research